Based on this YouTube video's total view count of 295K views and industry-standard rates, the estimated total earning is $207 - $590 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Tesamorelin: The Peptide That Changes Your Body Without Changing Your Weight with 295,109 views, 5,384 likes, and 937 comments. Experience the impact of this video content that has captured audience attention.

Rugiet: https://www.rugiet.com/DRALEX Use code DRALEX for 15% off 👕: https://labratlegion.com/ This video is for educational purposes only and is not medical advice. Consult a licensed healthcare provider about treatment decisions. Compounded medications are not FDA-approved and may differ from FDA-approved products. **Tesamorelin might be the most clinically proven fat loss peptide you've never heard of.** With over 800 patients studied in two Phase 3 clinical trials, FDA approval, and documented reductions in visceral belly fat of approximately 15–20%, this growth hormone-releasing hormone (GHRH) analog has something most peptides don't: substantial human clinical evidence. But there's a catch. Brand-name Egrifta can cost approximately **$11,000 per month**, and despite reducing dangerous visceral fat surrounding the organs, tesamorelin may barely change the number on your bathroom scale. In this video, Dr. Alex Tatem breaks down the science behind tesamorelin (Egrifta / Egrifta WR), how it works, and whether its claimed benefits for belly fat, muscle growth, sleep, recovery, and liver health actually hold up against clinical research. We cover the FDA clinical trials involving 806 patients, the difference between visceral and subcutaneous fat, growth hormone and IGF-1 signaling, tesamorelin vs sermorelin, CJC-1295 and ipamorelin, potential side effects, and the FDA regulations that help explain its staggering price. **In this video, you'll learn:** - How tesamorelin affects visceral fat without necessarily reducing body weight. - What two Phase 3 clinical trials actually found about abdominal fat loss. - Whether tesamorelin builds muscle or primarily increases lean mass through other mechanisms. - The evidence for potential sleep, recovery, and liver health benefits. - How tesamorelin compares with sermorelin, growth hormone, CJC-1295, and ipamorelin. - Why tesamorelin is classified as a biologic rather than a conventional peptide drug. - The FDA approval, safety concerns, blood glucose effects, and legal complications surrounding Egrifta. **⏱️ TIMESTAMPS / CHAPTERS** 00:00 – Tesamorelin: The Most Proven Fat Loss Peptide? 01:30 – What Would You Pay to Lose Visceral Fat? 02:22 – What Is Tesamorelin? GHRH Explained 03:26 – The Discovery of Growth Hormone Signaling 04:10 – DPP-4: Why Tesamorelin Lasts Longer 04:47 – HIV Lipodystrophy and Tesamorelin's Origin 05:37 – FDA Approval: The History of Egrifta 06:16 – How Tesamorelin Works: GH and IGF-1 07:37 – The Clinical Evidence Behind Tesamorelin 08:00 – 806 Patients: Two Phase 3 Trials 09:06 – Why Visceral Fat Drops but Weight Doesn't 11:23 – Does Tesamorelin Actually Build Muscle? 13:30 – Tesamorelin and Sleep: What the Studies Say 15:47 – Liver Fat Reduction and Metabolic Health 16:27 – Can Tesamorelin Improve Brain Function? 17:33 – Tesamorelin vs Sermorelin: Which Is Stronger? 19:03 – CJC-1295, DAC and Ipamorelin Compared 21:12 – The FDA's 40-Amino-Acid Rule 23:34 – Eli Lilly, Retatrutide and the FDA Lawsuit 24:37 – Why Tesamorelin Costs $11,000 a Month 25:57 – Sponsor: Rugiet 27:21 – Tesamorelin Side Effects and Safety 29:03 – What Happens When You Stop Taking It? 29:21 – Dosage, Compounding and Research Peptides 30:07 – Is Tesamorelin Actually Worth It? 31:28 – Final Thoughts and Lab Rat Legion **THE RESEARCH** Tesamorelin Phase 3 Clinical Trial (2007): https://doi.org/10.1056/NEJMoa072375 Pooled Phase 3 Clinical Trial Results (2010): https://doi.org/10.1210/jc.2010-0490 Tesamorelin and Liver Fat Reduction (2019): https://doi.org/10.1016/S2352-3018(19)30338-8 Growth Hormone Pulsatility and Insulin Sensitivity (2011): https://doi.org/10.1210/jc.2010-1587 Muscle Density and Body Composition: https://doi.org/10.14283/jfa.2018.45 **JOIN THE LAB RAT LEGION** Subscribe for evidence-based breakdowns of peptides, testosterone, TRT, growth hormone, metabolic health, longevity, and performance-enhancing compounds. Lab Rat Legion Merch: [Insert merch link] **QUESTION:** If a peptide could significantly reduce visceral fat, what would you pay monthly? A: Under $200 B: $200–$500 C: $500+ D: $0 — I've got a treadmill and a grudge. And comment **CJC** if you want a full breakdown of CJC-1295 and ipamorelin next. Tesamorelin is a prescription medication FDA-approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. It is not approved for general weight loss. Results from these studies should not be assumed to apply to healthy individuals seeking cosmetic fat loss or muscle growth. #Tesamorelin #Peptides #VisceralFat #Sermorelin #GrowthHormone

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.